nav-left cat-right
cat-right
The Ontario Bioscience Industy Strategic Implementation Plan

The Ontario Bioscience Industy Strategic Implement...

Over the past several months, OBEST has engaged >200 senior representatives from major stakeholder groups across Ontario’s life-sciences sector. The 6-month strategic planning Process has resulted in defined priorities and a plan for robust growth and commercial viability of the province’s bioscience industry. Click here to view the full article in PDF...
Canadian Life Sciences Industry Forecast 2011

Canadian Life Sciences Industry Forecast 2011...

PwC is pleased to present its fourth Canadian Life Sciences Industry Forecast, a survey conducted in collaboration with BIOTECanada. The online survey, conducted in August and September 2010, was completed by 100 respondents from corporate, academic, government and other organizations in the industry.  The report is designed to understand the challenges and concerns of the Canadian life sciences industry, explore new trends...
Ten Years After – Looking Back At A Biotech Boom

Ten Years After – Looking Back At A Biotech Boom...

Introduction There have historically been overlapping biotech booms and IPO windows, the three most recent boom/windows being 1995-1996, 1999-2001 and 2003-2005. Each of these boom/windows was impacted by positive external market forces, with the last two benefiting from the dot-com bubble and the post-9/11 market bounce, respectively. The driving factors within biotech have been different for each boom/window: 1995-1996 was...
The Burrill Report – Canadian Edition, April 2010

The Burrill Report – Canadian Edition, April...

Canada’s biotech stocks sizzled in the first quarter as they racked up impressive gains. The Burrill Canadian Biotech Index jumped 12 percent during the period. This is good news for the sector, which has languished for over three years. Low valuations have hampered the ability of public biotech companies to raise capital. The improving capital markets in Canada and the United States have helped bolster Toronto’s main...
ONTARIO’S LIFE SCIENCES COMMERCIALIZATION STRATEGY

ONTARIO’S LIFE SCIENCES COMMERCIALIZATION STRATE...

…But today our industry is being challenged by increased global competition from established and emerging life sciences jurisdictions, as well as by difficult economic conditions that include tight credit and market volatility. To compete successfully in the global marketplace, we know that our industry needs to continue to attract and nurture great scientific minds, increase collaboration among all the players –...
Discussion Notes: Quebec/Ontario Bioscience CEO Dinner, April 6, 2010

Discussion Notes: Quebec/Ontario Bioscience CEO Di...

What Quebec/Ontario Government funded programs are most effective? First and foremost, as entrepreneurs our duty is to create shareholder wealth with products and services the marketplace demands.  This cannot be substituted with or diverted by any government funding program. Quebec:  Tax holidays for key employees; tax exemption for new products developed in Quebec Quebec’s SR&ED tax credit regime is a...